Research of the Translational Molecular Imaging (TMI) Division focuses on the development and characterization of targeted imaging reporters for translating novel NMR detection techniques into diagnostic applications in oncology. We aim to visualize key molecular changes in cancer onset and progression. To this end, we explore novel approaches based on advanced NMR techniques like spin hyperpolarization and saturation transfer techniques in exchange-coupled spin systems. We also investigate biomaterials science aspects of established contrast agents with respect to their biosafety and the understanding of their biochemical fate.